(MedPage Today) — The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer announced on Friday.
Elinzanetant is now the first and only dual neurokinin (NK) targeted therapy -…
Source link : https://www.medpagetoday.com/obgyn/menopause/118141
Author :
Publish date : 2025-10-24 19:54:00
Copyright for syndicated content belongs to the linked Source.
